77 related articles for article (PubMed ID: 36380313)
1. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer.
Tazawa H; Suzuki T; Saito A; Ishikawa A; Komo T; Sada H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Kuraoka K; Tashiro H
J Gastrointest Surg; 2022 Feb; 26(2):305-313. PubMed ID: 34379296
[TBL] [Abstract][Full Text] [Related]
2. Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation.
Assani G; Yessoufou A; Xiong Y; Segbo J; Yu X; Zhou F; Zhou Y
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1849-1856. PubMed ID: 31244309
[TBL] [Abstract][Full Text] [Related]
3. CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
Zhu Y; Zhang Z; Jiang Z; Liu Y; Zhou J
Front Genet; 2020; 11():369. PubMed ID: 32425977
[TBL] [Abstract][Full Text] [Related]
4. NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity.
Zheng L; Li M; Wei J; Chen S; Xue C; Duan Y; Tang F; Li G; Xiong W; She K; Deng H; Zhou M
PLoS One; 2023; 18(9):e0292212. PubMed ID: 37769000
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019.
Luo L; Zheng Y; Li M; Lin X; Li X; Li X; Cui L; Luo H
Front Genet; 2020; 11():575770. PubMed ID: 33193689
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients.
Villalba M; Exposito F; Pajares MJ; Sainz C; Redrado M; Remirez A; Wistuba I; Behrens C; Jantus-Lewintre E; Camps C; Montuenga LM; Pio R; Lozano MD; de Andrea C; Calvo A
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817025
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.
Man YG; Stojadinovic A; Mason J; Avital I; Bilchik A; Bruecher B; Protic M; Nissan A; Izadjoo M; Zhang X; Jewett A
J Cancer; 2013; 4(1):84-95. PubMed ID: 23386907
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.
Kim S
Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.
Xu X; Sun T; Jing J
BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane protease serine 4 promotes thyroid cancer proliferation via CREB phosphorylation.
Guan H; Liang W; Liu J; Wei G; Li H; Xiu L; Xiao H; Li Y
Thyroid; 2015 Jan; 25(1):85-94. PubMed ID: 25244400
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.
Larzabal L; Nguewa PA; Pio R; Blanco D; Sanchez B; RodrÃguez MJ; Pajares MJ; Catena R; Montuenga LM; Calvo A
Br J Cancer; 2011 Nov; 105(10):1608-14. PubMed ID: 22067904
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of TMPRSS4 expression in patients with breast cancer.
Liang B; Wu M; Bu Y; Zhao A; Xie F
Med Oncol; 2013 Jun; 30(2):497. PubMed ID: 23420063
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
